Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTungsten west Regulatory News (TUN)

Share Price Information for Tungsten west (TUN)

Share Price is delayed by 15 minutes
Get Live Data
38.75    -0.55 (-1.40%)
Bid:
38.50
Ask:
39.00
Spread: 0.50 (1.299%)
Market Cap: £483.47m
TUN Live PriceLast checked at - London Stock Exchange

Intraday Tungsten west Share Chart

Successful Processing Trial

7 Nov 2025 07:00

RNS Number : 5839G
Tungsten West PLC
07 November 2025
 

7 November 2025

Tungsten West Plc

("Tungsten West", the "Company" or the "Group")

 

Successful Processing Trial

 

Tungsten West (LON:TUN), the mining company focused on restarting production at the Hemerdon tungsten and tin mine ("Hemerdon" or the "Project") in Devon, UK, is pleased to report positive progress from the ongoing processing trial at Hemerdon.

 

The trial is being undertaken as part of a programme focused on testing and optimising the performance of key sections of the mineral processing facility. The programme forms part of the Company's approach to de-risking operations and gathering technical data essential for the planned restart of full-scale production.

 

As part of the trial programme, the Company has generated its first trial tungsten concentrate.

 

Jeff Court, CEO of Tungsten West, commented:

"The progress we are making in this processing trial is an important milestone in restarting operations at Hemerdon and provides confidence to our neighbours, the Environment Agency, our investors and off-takers that we are moving towards production. We have ensured that all activities throughout this trial have been conducted to high environmental and operational standards.

 

"As the need for a diversified source of tungsten intensifies, Hemerdon becomes an even more important strategic asset."

 

 

Tungsten West team at the Hemerdon Mineral Processing Facility with trial tungsten concentrate.

 

Ends

 

For further information, please contact:

 

Enquiries

Tungsten West

Jeff Court

Tel: +44 (0) 1752 278500

 

Strand Hanson

(Nominated Adviser and Financial Adviser)

James Spinney / James Dance / Abigail Wennington

Tel: +44 (0) 207 409 3494

BlytheRay

(Financial PR)

Tim Blythe / Megan Ray

Tel: +44(0) 20 7138 3204

Email: tungstenwest@blytheray.com

 

Hannam & Partners

(Broker)

Andrew Chubb / Matt Hasson / Jay Ashfield

Tel: +44 (0)20 7907 8500

 

Follow us on X @TungstenWest

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFFLLTLRIIE
Date   Source Headline
21st May 20267:00 amRNSQ1 2026 Project Funding and Debt Update
23rd Apr 20263:11 pmRNSTR-1: Notification of major holdings
13th Apr 20263:13 pmRNSTR-1: Notification of major holdings
13th Apr 20261:35 pmRNSTR-1: Notification of major holdings
8th Apr 20267:00 amRNSQ1 2026 Project Update
18th Mar 202611:12 amRNSTR-1: Notification of major holdings
16th Mar 20267:00 amRNSTR-1: Notification of major holdings
16th Mar 20267:00 amRNSTR-1: Notification of major holdings
12th Mar 20267:00 amRNSConversion of B Shares
3rd Mar 202610:57 amRNSTR-1: Notification of major holdings
3rd Mar 202610:30 amRNSTR-1: Notification of major holdings
3rd Mar 20267:00 amRNSTR-1: Notification of major holdings
2nd Mar 20266:17 pmRNSTR-1: Notification of major holdings
27th Feb 20264:57 pmRNSTR-1: Notification of major holdings
26th Feb 20262:16 pmRNSResults of General Meeting
25th Feb 20267:00 amRNSTR-1: Notification of major holdings
24th Feb 20262:29 pmRNSTR-1: Notification of major holdings
24th Feb 20268:01 amRNSTR-1: Notification of major holdings
23rd Feb 20262:59 pmRNSConversion of B Shares
16th Feb 20267:00 amRNSProject Update
13th Feb 20263:42 pmRNSTR-1: Notification of major holdings
12th Feb 20268:49 amRNSTR-1: Notification of major holdings
12th Feb 20267:00 amRNSTR-1: Notification of major holdings
11th Feb 202611:36 amRNSTR-1: Notification of major holdings
10th Feb 202610:12 amRNSTR-1: Notification of major holdings
9th Feb 20266:27 pmRNSPosting of Circular and Notice of General Meeting
9th Feb 20265:47 pmRNSTR-1: Notification of major holdings
9th Feb 20264:28 pmRNSTR-1: Notification of major holdings
6th Feb 20267:55 amRNSResult of Retail Offer
6th Feb 20267:15 amRNSResult of Bookbuild and Subscription Raising
5th Feb 20267:01 amRNSRetail Offer by RetailBook
5th Feb 20267:00 amRNSSubscription and Proposed Placing
2nd Feb 20267:00 amRNSProject Update
30th Jan 20262:33 pmRNSResults of General Meeting
15th Jan 20268:17 amRNSPosting of Circular and Notice of General Meeting
13th Jan 20268:45 amRNSReplacement: TR-1: Notification of major holdings
8th Jan 20263:30 pmRNSTR-1: Notification of major holdings
8th Jan 20263:13 pmRNSTR-1: Notification of major holdings
8th Jan 20267:00 amRNSTR-1: Notification of major holdings
7th Jan 20267:00 amRNSDirector Dealings
7th Jan 20267:00 amRNSTR-1: Notification of major holdings
5th Jan 20267:00 amRNSDirector Dealings
2nd Jan 20267:00 amRNSConvertible Loan Note Conversion
2nd Jan 20267:00 amRNSConvertible Loan Note Conversion
24th Dec 20257:00 amRNSResults for the six months ended 30 September 2025
23rd Dec 20257:00 amRNSExercise of Options & TVR
23rd Dec 20257:00 amRNSExercise of Options & TVR
9th Dec 20257:00 amRNSBridge Loan, Project Financing & CLN Update
5th Dec 20257:00 amRNSBoard Change
26th Nov 20257:00 amRNSEPC Agreement for New Build Construction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.